Study S001218

The Effect of Semaglutide on Pituitary Function

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04865744
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: DOUBLE
Status: COMPLETED
Enrollment: 10
Start: 2021-05-19
Primary completion: 2021-09-23
Lead sponsor: University of Tartu
Conditions: Healthy
Interventions: DRUG:Semaglutide 7 MG Oral Tablet; DRUG:Placebo; DRUG:Semaglutide 14 MG Oral Tablet
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Growth hormone peak [60, 90, 120, 150, 180 and 240 minutes after study medication administration]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.